fda warning letter semaglutide october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Drug Recalls and Warnings:
Description
The initial week at the ozempic 2mg dose for weight loss typically brings noticeable changes for Miami residents accustomed to lower dosage effects and previous appetite levels

Bottom line: when patients need something different than whats commercially available, compounding pharmacies like Empower can fill the gap

Both concentrations keep every weekly dose within a single U-100 syringe (100 units / 1.0 mL)

"People are always like, 'Oh, It's because of rapid weight loss," noted Michaels

Healthcare professionals should maintain awareness that GLP-1/GIP medicines, whilst highly effective for their intended indications, require holistic management addressing not only glycaemic control and weight but also nutritional status and overall metabolic health
